A pharmaceutical company is developing a new drug to treat a rare disease. Initial trials show that patients taking the drug experienced a 30% reduction in symptoms, while those on a placebo experienced only a 5% reduction. The company concludes that the drug is effective. Which of the following, if true, would be most important to know in evaluating the company's conclusion?
- AThe cost of manufacturing the new drug compared to existing treatments.
- BThe number of patients who participated in the initial trials for the drug.
- CWhether the drug has any significant side effects not observed in the placebo group.
- DWhether the 30% reduction in symptoms is considered clinically significant for patients with this disease.
Show answer & explanationAnswer & explanation
Correct answer: D. Whether the 30% reduction in symptoms is considered clinically significant for patients with this disease.
The company concludes the drug is 'effective' based on a 30% symptom reduction. However, 'effective' in a medical context typically means 'clinically significant' or 'meaningful to patient health'. If a 30% reduction, while statistically better than placebo, does not actually improve a patient's quality of life or disease progression in a meaningful way, then the drug would not be truly 'effective' in the practical sense, making this the most important information.
Why the other options are wrong
- A. Cost is a factor in commercial viability and accessibility, but not in the *effectiveness* of the drug itself.
- B. The number of patients is important for statistical significance, but even if statistically significant, the *clinical* significance (A) is paramount for determining true effectiveness.
- C. Side effects are crucial for overall drug evaluation and approval, but they relate to *safety and tolerability*, not directly to the *effectiveness* of the drug in reducing symptoms, which is the conclusion being evaluated.
Clinical Significance
The practical importance of a treatment effect, indicating whether the observed change is meaningful for a patient's health or quality of life, beyond just statistical significance.
- Distinguished from statistical significance.
- Focuses on real-world impact.
- Often determined by expert consensus or patient-reported outcomes.
Memory trick: When a drug is 'effective' claimed, check if the patient's life is truly tamed!